Skip to main content
OpenTrials
Completed

NCT Number: NCT07534969

Fixed-Interval vs. On-Demand Analgesia After Vacuum-Assisted Delivery: RCT

This randomized controlled trial evaluates the effectiveness of scheduled versus on-demand pain relief protocols in managing postpartum pain during the first 24 hours after vacuum-assisted delivery.

Objectives:

Primary: Compare pain reduction (VAS scores) between the two protocols. Secondary: Assess extended pain relief use, breastfeeding rates, maternal satisfaction, and postpartum hospitalization duration.

Design:

Participants: 200 women aged 18-45, randomized into two groups:

Scheduled Pain Relief: Acetaminophen and diclofenac every 8 hours. On-Demand Pain Relief: Same medications administered upon request. Pain levels are assessed via VAS every 8 hours and around medication times. All participants receive IV acetaminophen immediately postpartum and additional pain relief for breakthrough pain as needed.

Data Collection: Demographics, delivery details, pain scores, medication use, breastfeeding rates, and satisfaction (using the Birth Satisfaction Scale-BSS-R) will be recorded.

Significance: The study aims to fill a gap in the literature on postpartum pain management for vacuum-assisted deliveries, improving care and maternal outcomes.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–45 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Meir Medical Center

Kfar Saba, 4861027, Israel

About this study

Study Objectives:

  • Primary Objective: Compare the effectiveness of scheduled versus on-demand pain relief protocols following vacuum-assisted delivery during the first 24 hours postpartum, using the VAS (Visual Analog Scale) for pain (1-10).
  • Secondary Objectives:
  • Measure VAS scores every 8 hours during the first 24 hours postpartum.
  • Assess the use of pain relief beyond 24 hours postpartum, including the use of morphine.
  • Evaluate breastfeeding rates, satisfaction with the birth experience, and length of postpartum hospitalization.

Study Design:

  • Recruitment: Women will be recruited immediately after vacuum-assisted delivery.
  • Participants will provide informed consent and be assigned a unique anonymous identifier for data collection.
  • All participants will receive 1,000 mg of IV acetaminophen immediately postpartum, per departmental protocol.
  • Participants will be randomized (1:1) into two groups:
  • Scheduled Pain Relief Group: Oral acetaminophen (1 g) and diclofenac (50 mg) every 8 hours for the first 24 hours postpartum.
  • On-Demand Pain Relief Group: The same oral medications as the scheduled group but administered only upon request.
  • After the first 24 hours postpartum, both groups will receive pain relief on-demand.
  • Women experiencing breakthrough pain despite their assigned protocol will receive additional medication as needed, and such interventions will be recorded.

Pain Assessment:

Pain levels will be assessed using the VAS scale every 8 hours, and one hour before and after administering pain relief.

Data Collection:

  • Demographics: Age, BMI, parity, gestational age at delivery.
  • Delivery details:
  • Mode of labor onset (spontaneous or induced).
  • Cervical ripening method (prostaglandins or balloon).
  • Use of oxytocin during labor.
  • Duration of active and second stages of labor.
  • Use of epidural anesthesia.
  • Perineal tears (grades 1-4).
  • Estimated and excessive blood loss.
  • Placental separation (manual removal or uterine exploration).
  • Neonatal weight.
  • Outcomes:
  • Pain scores (VAS)
  • Medication use
  • Breastfeeding rates
  • Birth satisfaction (assessed via the validated Birth Satisfaction Scale-BSS-R).

Study Population:

  • Inclusion Criteria: Women aged 18-45 who underwent vacuum-assisted delivery of a singleton pregnancy.
  • Exclusion Criteria:
  • Allergy to acetaminophen or NSAIDs.
  • Chronic pain conditions (e.g., endometriosis, fibromyalgia).
  • Cesarean deliveries.
  • Multiple pregnancies.

Sample Size:

Based on prior studies, 100 women per group are required to detect a 33% reduction in VAS scores (from 6 ± 2 to 4 ± 2) with 80% power and a 5% significance level. A total of 200 participants will be recruited.

Duration:

The study will run for five years. Data will be securely stored for 15 years in a locked cabinet and password-protected computer accessible only to the principal investigator.

Statistical Analysis:

Data will be analyzed using SPSS software. ANOVA will be used to compare outcomes between groups.

This study addresses a gap in literature by investigating pain management protocols specifically for vacuum-assisted deliveries, aiming to improve postpartum care and maternal satisfaction.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Women aged 18-45 who underwent vacuum-assisted delivery of a singleton pregnancy.

Exclusion criteria

  • Allergy to acetaminophen or NSAIDs.
  • Chronic pain conditions (e.g., endometriosis, fibromyalgia).
  • Cesarean deliveries.
  • Multiple pregnancies.
  • Normal vaginal delivery.

Treatment and study plan

Scheduled Pain relief drugs administered during the first 24 hours postpartum every 8 hours.

Drug

Oral acetaminophen (1 g) and diclofenac (50 mg) administered during the first 24 hours postpartum together every 8 houers

Other names: Scheduled

On demand analgesia

Other

Administration of analgesics upon patient request

Other names: On demand

Primary outcomes

  1. Scheduled versus on-demand pain relief protocols following vacuum-assisted delivery during the first 24 hours postpartum

    Time frame: From enrollment until discharge following delivery, up to 1 week.

    Compare the effectiveness of scheduled versus on-demand pain relief protocols following vacuum-assisted delivery during the first 24 hours postpartum, using the VAS (Visual Analog Scale) for pain (1-10).

Secondary outcomes

  1. Pain relif use, hospitalization, breastfeeding and maternal satisfaction.

    Time frame: From enrollment until discharge following delivery, up to 1 week.

    group differences in VAS pain scores at predefined 8-hour intervals during the first 24 hours postpartum, use of additional analgesia beyond 24 hours postpartum, breastfeeding rates, length of postpartum hospitalization and maternal satisfaction.

  2. Baseline maternal and obstetric characteristics

    Time frame: From enrollment until discharge following delivery, up to 1 week.

    Maternal age (Years), body mass index (BMI), parity, and gestational age at delivery. (weeks)

  3. Labor and delivery characteristics

    Time frame: From enrollment until discharge following delivery, up to 1 week.

    mode of labor onset, cervical ripening method (prostaglandins, balloon catheter, or combined methods), use of oxytocin augmentation, epidural anesthesia, and indication for vacuum-assisted delivery (non-reassuring fetal heart rate, prolonged second stage, or maternal exhaustion)

  4. Delivery outcomes and maternal complications

    Time frame: From enrollment until discharge following delivery, up to 1 week.

    Episiotomy, degree of perineal lacerations (1-4 degree), postpartum hemorrhage, maternal fever, manual removal of the placenta, uterine revision, urinary retention, retained products of conception.

Sponsors and collaborators

Lead sponsor

Yael Yagur

Other

Collaborators

  • Meir Medical Center

Registry information

Official study title

Fixed-time Interval vs. On-demand Analgesia Following Vacuum-assisted Vaginal Delivery: A Randomized Controlled Trial

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Apr 16, 2026
Registry last updated
Apr 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.